Vertex Pharmaceuticals Incorporated (VRTX) Habari na Bei za Hisa

(USD)	Des 2023	Mabadiliko Tangu Mwaka Uliopita
Mapato	2.52B	9.34%
Matumizi ya uendeshaji wa biashara	369.10M	38.03%
Mapato halisi	968.80M	18.31%
Kiwango cha faida halisi	38.48	8.21%
Mapato kwa kila hisa	4.20	11.70%
EBITDA	1.00B	-8.49%
Asilimia ya kodi ya mapato	15.58%	—

Taarifa ya Hali ya Kifedha

Jumla ya mali

Jumla ya dhima

(USD)	Des 2023	Mabadiliko Tangu Mwaka Uliopita
Uwekezaji wa pesa taslimu na vipindi vifupi	11.22B	4.08%
Jumla ya mali	22.73B	25.23%
Jumla ya dhima	5.15B	21.51%
Jumla ya hisa	17.58B	—
hisa zilizosalia	258.31M	—
Uwiano wa bei na thamani	6.14	—
Faida inayotokana na mali	10.75%	—
Faida inayotokana mtaji	13.41%	—

Mtiririko wa pesa

Mabadiliko halisi ya pesa taslimu

(USD)	Des 2023	Mabadiliko Tangu Mwaka Uliopita
Mapato halisi	968.80M	18.31%
Pesa kutokana na shughuli	234.60M	-78.25%
Pesa kutokana na uwekezaji	-886.50M	-604.84%
Pesa kutokana na ufadhili	-119.80M	-398.01%
Mabadiliko halisi ya pesa taslimu	-744.30M	-155.75%
Mtiririko huru wa pesa	448.38M	-47.72%

Kuhusu

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in South Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia

Afisa Mkuu Mtendaji (CEO)

Reshma Kewalramani

Ilianzishwa

1989

Makao Makuu

Boston, Massachusetts
Marekani

Tovuti

vrtx.com

Wafanyakazi

5,400